Reoperation among patients with recurrent glioblastoma multiforme (GBM) is associated with better overall survival (OS) and post-progression survival (PPS), a meta-analysis of 21 studies has demonstrated.
Data on the use of immune checkpoint inhibitors (ICIs) in glioblastoma multiforme (GBM) are still immature or do not show clear-cut benefits, but they still have a potential as a therapeutic modality with clarification of molecular mechanisms and predictive biomarkers, a review has reported.
Liquid biopsy is demonstrated to be a quick, inexpensive diagnostic modality that can be performed multiple times to help establish a diagnosis of glioblastoma multiforme (GBM) without high-risk neurosurgical interventions.
Blood pressure lowering medications and statins do not prevent cognitive and functional decline in elderly patients, according to results of the HOPE-3 trial* presented at the Scientific Sessions of the American Heart Association (AHA 2016) held recently in New Orleans, Louisiana, US.
Roshini Claire Anthony spoke with Adjunct Associate Professor Gamaliel Tan, head and senior orthopaedic consultant at Ng Teng Fong Hospital in Singapore, on how GPs can help diagnose and treat lower back pain.
A 10 or 20 mg/kg daily dose of cannabidiol could almost halve the risk of seizures in children with Dravet syndrome, according to the phase III GWPCARE2* study presented at the American Academy of Neurology annual meeting (AAN 2019).
Use of the antihypertensive drug isradipine did not reduce the progression of Parkinson’s disease, according to the STEADY-PD III* study presented at the American Academy of Neurology annual meeting (AAN 2019).
Among patients with a recent acute ischaemic stroke treated with thrombolytic therapy, intensive blood pressure (BP)-lowering conferred no additional benefit in functional recovery compared with guideline-recommended BP-lowering, despite a reduced risk of intracranial haemorrhage with intensive therapy, according to results of the ENCHANTED* trial.